Michael C. Heinrich
Portland VA Medical Center
Portland
USA
Name/email consistency: high
- Crenolanib inhibits the drug-resistant PDGFRA D842V mutation associated with imatinib-resistant gastrointestinal stromal tumors. Heinrich, M.C., Griffith, D., McKinley, A., Patterson, J., Presnell, A., Ramachandran, A., Debiec-Rychter, M. Clin. Cancer Res. (2012)
- Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors. Heinrich, M.C., Marino-Enriquez, A., Presnell, A., Donsky, R.S., Griffith, D.J., McKinley, A., Patterson, J., Taguchi, T., Liang, C.W., Fletcher, J.A. Mol. Cancer Ther. (2012)
- Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Heinrich, M.C., Joensuu, H., Demetri, G.D., Corless, C.L., Apperley, J., Fletcher, J.A., Soulieres, D., Dirnhofer, S., Harlow, A., Town, A., McKinley, A., Supple, S.G., Seymour, J., Di Scala, L., van Oosterom, A., Herrmann, R., Nikolova, Z., McArthur, A.G. Clin. Cancer Res. (2008)
- Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. Heinrich, M.C., Maki, R.G., Corless, C.L., Antonescu, C.R., Harlow, A., Griffith, D., Town, A., McKinley, A., Ou, W.B., Fletcher, J.A., Fletcher, C.D., Huang, X., Cohen, D.P., Baum, C.M., Demetri, G.D. J. Clin. Oncol. (2008)
- Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group. Heinrich, M.C., Owzar, K., Corless, C.L., Hollis, D., Borden, E.C., Fletcher, C.D., Ryan, C.W., von Mehren, M., Blanke, C.D., Rankin, C., Benjamin, R.S., Bramwell, V.H., Demetri, G.D., Bertagnolli, M.M., Fletcher, J.A. J. Clin. Oncol. (2008)
- Does tumor mutational status correlate with clinical response to imatinib? Heinrich, M.C., Corless, C.L. Nat. Clin. Pract. Oncol (2006)
- Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). Heinrich, M.C., McArthur, G.A., Demetri, G.D., Joensuu, H., Bono, P., Herrmann, R., Hirte, H., Cresta, S., Koslin, D.B., Corless, C.L., Dirnhofer, S., van Oosterom, A.T., Nikolova, Z., Dimitrijevic, S., Fletcher, J.A. J. Clin. Oncol. (2006)
- Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. Heinrich, M.C., Corless, C.L., Blanke, C.D., Demetri, G.D., Joensuu, H., Roberts, P.J., Eisenberg, B.L., von Mehren, M., Fletcher, C.D., Sandau, K., McDougall, K., Ou, W.B., Chen, C.J., Fletcher, J.A. J. Clin. Oncol. (2006)
- Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. Heinrich, M.C., Corless, C.L. J. Surg. Oncol (2005)
- Targeting FLT3 kinase in acute myelogenous leukemia: progress, perils, and prospects. Heinrich, M.C. Mini. Rev. Med. Chem (2004)
- PDGFRA activating mutations in gastrointestinal stromal tumors. Heinrich, M.C., Corless, C.L., Duensing, A., McGreevey, L., Chen, C.J., Joseph, N., Singer, S., Griffith, D.J., Haley, A., Town, A., Demetri, G.D., Fletcher, C.D., Fletcher, J.A. Science (2003)
- Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. Heinrich, M.C., Corless, C.L., Demetri, G.D., Blanke, C.D., von Mehren, M., Joensuu, H., McGreevey, L.S., Chen, C.J., Van den Abbeele, A.D., Druker, B.J., Kiese, B., Eisenberg, B., Roberts, P.J., Singer, S., Fletcher, C.D., Silberman, S., Dimitrijevic, S., Fletcher, J.A. J. Clin. Oncol. (2003)
- Is KIT an important therapeutic target in small cell lung cancer?. Heinrich, M.C. Clin. Cancer Res. (2003)
- Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. Heinrich, M.C., Blanke, C.D., Druker, B.J., Corless, C.L. J. Clin. Oncol. (2002)
- Posttranscriptional cell cycle-dependent regulation of human FANCC expression. Heinrich, M.C., Silvey, K.V., Stone, S., Zigler, A.J., Griffith, D.J., Montalto, M., Chai, L., Zhi, Y., Hoatlin, M.E. Blood (2000)
- Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Heinrich, M.C., Griffith, D.J., Druker, B.J., Wait, C.L., Ott, K.A., Zigler, A.J. Blood (2000)